Cambridge Investment Research Advisors, Inc. Tekla Life Sciences Investors Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$13.38 - $14.33 $6,703 - $7,179	501 Added 4.81%	10,927 $149,000
Q4 2023 Feb 09, 2024	SELL	$11.35 - $13.6 $12,099 - $14,497	-1,066 Reduced 9.28%	10,426 $140,000
Q3 2023 Oct 24, 2023	SELL	$12.38 - $13.69 $9,470 - $10,472	-765 Reduced 6.24%	11,492 $143,000
Q2 2023 Jul 13, 2023	BUY	$13.13 - $14.17 $2,757 - $2,975	210 Added 1.74%	12,257 $166,000
Q1 2023 May 11, 2023	BUY	$13.37 - $14.94 $161,068 - $179,982	12,047 New	12,047 $168,000
Q2 2022 Jul 13, 2022	BUY	$13.11 - $17.02 $4,562 - $5,922	348 Added 2.33%	15,278 $217,000
Q1 2022 May 12, 2022	BUY	$15.35 - $19.29 $30,423 - $38,232	1,982 Added 15.31%	14,930 $246,000
Q4 2021 Feb 03, 2022	BUY	$18.5 - $21.59 $13,616 - $15,890	736 Added 6.03%	12,948 $248,000
Q3 2021 Nov 02, 2021	BUY	$20.27 - $22.67 $8,189 - $9,158	404 Added 3.42%	12,212 $254,000
Q2 2021 Aug 10, 2021	BUY	$19.14 - $21.44 $226,005 - $253,163	11,808 New	11,808 $253,000
Q4 2019 Feb 04, 2020	SELL	$14.63 - $17.84 $724,521 - $883,490	-49,523 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$15.09 - $17.09 $40,516 - $45,886	-2,685 Reduced 5.14%	49,523 $747,000
Q3 2019 Oct 28, 2019	BUY	$15.09 - $17.09 $1,237 - $1,401	82 Added 0.16%	52,208 $788,000
Q2 2019 Aug 15, 2019	BUY	$15.54 - $17.47 $44,491 - $50,016	2,863 Added 5.81%	52,126 $0
Q1 2019 May 08, 2019	BUY	$15.5 - $17.9 $82,274 - $95,013	5,308 Added 12.08%	49,263 $0
Q4 2018 Feb 05, 2019	SELL	$13.99 - $20.35 $124,175 - $180,626	-8,876 Reduced 16.8%	43,955 $664,000
Q3 2018 Nov 02, 2018	BUY	$18.89 - $20.49 $23,876 - $25,899	1,264 Added 2.45%	52,831 $0
Q2 2018 Aug 10, 2018	SELL	$18.13 - $19.4 $11,766 - $12,590	-649 Reduced 1.24%	51,567 $0
Q1 2018 May 09, 2018	BUY	$18.92 - $21.52 $18,201 - $20,702	962 Added 1.88%	52,216 $0
Q4 2017 Feb 22, 2018	BUY	$18.31 - $22.24 $151,771 - $184,347	8,289 Added 19.29%	51,254 $0
Q3 2017 Nov 07, 2017	BUY	$20.12 - $21.88 $32,292 - $35,117	1,605 Added 3.88%	42,965 $923,000
Q2 2017 Aug 08, 2017	BUY	N/A	41,360	41,360 $862,000

Others Institutions Holding HQL

# of Institutions

Shares Held

9.31M

Call Options Held

Put Options Held

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$46.3 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.5 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.61 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.33 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.63 Million
0.14% of portfolio

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account